MIF promotes classical activation and conversion of inflammatory Ly6C high monocytes into TipDCs during murine toxoplasmosis

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Ruiz Rosado, Juan De Dios ^a   Olguín, Jonadab E ^a   Juárez Avelar, Imelda ^a   Saavedra, Rafael ^b   Terrazas, Luis I ^a   Robledo Avila, Frank H ^c   Vazquez Mendoza, Alicia ^a   Fernández, Jacquelina ^b   Satoskar, Abhay R ^d   Partida Sánchez, Santiago ^c   Rodriguez Sosa, Miriam ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCLONAL ANTIBODY; RECOMBINANT CYTOKINE; RECOMBINANT MACROPHAGE MIGRATION INHIBITION FACTOR; UNCLASSIFIED DRUG; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; GALACTOSAMINE; ISOMERASE; LIPOPOLYSACCHARIDE; MIF PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ADOPTIVE TRANSFER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EXPERIMENTAL INFECTION; FEMALE; INFECTION RESISTANCE; MALE; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEAL CAVITY; PERITONEAL EXUDATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOXOPLASMOSIS; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MICROBIOLOGY; NEUTROPHIL; PATHOGENICITY; PSEUDOMONAS AERUGINOSA;

ANIMALS; ENTEROTOXINS; FEMALE; GALACTOSAMINE; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; INTRAMOLECULAR OXIDOREDUCTASES; LIPOPOLYSACCHARIDES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MONOCYTES; NEUTROPHILS; PSEUDOMONAS AERUGINOSA; TOXOPLASMOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84962217296     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/9101762     Document Type: Article

References (59)

1. F. G. Araujo and J. S. Remington, "Toxoplasmosis in immunocompromised patients, " European Journal of Clinical Microbiology, vol. 6, no. 1, pp. 1-2, 1987.
2. R. T. Gazzinelli, S. Hieny, T. A. Wynn, S. Wolf, and A. Sher, "Interleukin-12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts, " Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 13, pp. 6115-6119, 1993.
3. Y. Suzuki, M. A. Orellana, R. D. Schreiber, and J. S. Remington, "Interferon-γ: the major mediator of resistance against Toxoplasma gondii, " Science, vol. 240, no. 4851, pp. 516-518, 1988.
4. G. S. Yap and A. Sher, "Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function, " Immunobiology, vol. 201, no. 2, pp. 240-247, 1999.
5. R. T. Gazzinelli, S. Hayashi, M. Wysocka et al. , "Role of IL-12 in the initiation of cell mediated immunity by Toxoplasma gondii and its regulation by IL-10 and nitric oxide, " The Journal of Eukaryotic Microbiology, vol. 41, no. 5, p. 9S, 1994.
6. S. K. Bliss, B. A. Butcher, and E. Y. Denkers, "Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection, " The Journal of Immunology, vol. 165, no. 8, pp. 4515-4521, 2000.
7. S. K. Bliss, A. J. Marshall, Y. Zhang, and E. Y. Denkers, "Human polymorphonuclear leukocytes produce IL-12, TNF-α, and the chemokines macrophage-inflammatory protein-1α and -1β in response to Toxoplasma gondii antigens, " The Journal of Immunology, vol. 162, no. 12, pp. 7369-7375, 1999.
8. S. K. Bliss, Y. Zhang, and E. Y. Denkers, "Murine neutrophil stimulation by Toxoplasma gondii antigen drives high level production of IFN-γ-independent IL-12, " The Journal of Immunology, vol. 163, no. 4, pp. 2081-2088, 1999.
9. P. M. Robben, D. G. Mordue, S. M. Truscott, K. Takeda, S. Akira, and L. D. Sibley, "Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype, " The Journal of Immunology, vol. 172, no. 6, pp. 3686-3694, 2004.
10. R. S. Goldszmid, P. Caspar, A. Rivollier et al. , "NK cellderived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection, " Immunity, vol. 36, no. 6, pp. 1047-1059, 2012.
11. M. Mashayekhi, M. M. Sandau, I. R. Dunay et al. , "CD8α + dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites, " Immunity, vol. 35, no. 2, pp. 249-259, 2011.
12. F. Yarovinsky, D. Zhang, J. F. Andersen et al. , "Immunology: TLR11 activation of dendritic cells by a protozoan profilin-like protein, " Science, vol. 308, no. 5728, pp. 1626-1629, 2005.
13. E. Y. Denkers, R. T. Gazzinelli, D. Martin, and A. Sher, "Emergence of NK1. 1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii inMHC class I-deficient mice, " Journal of ExperimentalMedicine, vol. 178, no. 5, pp. 1465-1472, 1993.
14. A. Sher, I. P. Oswald, S. Hieny, and R. T. Gazzinelli, "Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α, " Journal of Immunology, vol. 150, no. 9, pp. 3982-3989, 1993.
15. J. P. Gigley, B. A. Fox, and D. J. Bzik, "Cell-mediatedimmunity to Toxoplasma gondii develops primarily by localTh1host immune responses in the absence of parasite replication, " The Journal of Immunology, vol. 182, no. 2, pp. 1069-1078, 2009.
16. L. Casciotti, K. H. Ely, M. E. Williams, and I. A. Khan, "CD8+-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4+ T cells, " Infection and Immunity, vol. 70, no. 2, pp. 434-443, 2002.
17. R. Gazzinelli, Y. Xu, S. Hieny, A. Cheever, and A. Sher, "Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii, " The Journal of Immunology, vol. 149, no. 1, pp. 175-180, 1992.
18. E. Jongert, A. Lemiere, J. van Ginderachter, S. de Craeye, K. Huygen, and S. DSouza, "Functional characterization of in vivo effector CD4+ and CD8+ T cell responses in acute Toxoplasmosis: an interplay of IFN-γ and cytolytic T cells, " Vaccine, vol. 28, no. 13, pp. 2556-2564, 2010.
19. J. D. D. Rosado and M. Rodriguez-Sosa, "Macrophage migration inhibitory factor (MIF): a Key player in protozoan infections, " International Journal of Biological Sciences, vol. 7, no. 9, pp. 1239-1256, 2011.
20. A. R. Satoskar, M. Bozza, M. R. Sosa, G. Lin, and J. R. David, "Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection, " Infection and Immunity, vol. 69, no. 2, pp. 906-911, 2001.
21. J. L. Reyes, L. I. Terrazas, B. Espinoza et al. , "Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi Infection, " Infection and Immunity, vol. 74, no. 6, pp. 3170-3179, 2006.
22. G. A. Awandare, P. G. Kremsner, J. B. Hittner et al. , "Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history ofmildmalaria relative to children with a history of severe malaria, " The American Journal of TropicalMedicine andHygiene, vol. 76, no. 6, pp. 1033-1036, 2007.
23. S. Juttner, J. Bernhagen, C. N. Metz, M. Rollinghoff, R. Bucala, and A. Gessner, "Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-α, " Journal of Immunology, vol. 161, no. 5, pp. 2383-2390, 1998.
24. M. Flores, R. Saavedra, R. Bautista et al. , "Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii, " The FASEB Journal, vol. 22, no. 10, pp. 3661-3671, 2008.
25. C. A. Terrazas, I. Juarez, L. I. Terrazas, R. Saavedra, E. A. Calleja, and M. Rodriguez-Sosa, "Toxoplasma gondii: impairedmaturation and pro-inflammatory response of dendritic cells in MIFdeficient mice favors susceptibility to infection, " Experimental Parasitology, vol. 126, no. 3, pp. 348-358, 2010.
26. H. C. Probst, K. Tschannen, B. Odermatt, R. Schwendener, R. M. Zinkernagel, and M. Van Den Broek, "Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells, " Clinical and Experimental Immunology, vol. 141, no. 3, pp. 398-404, 2005.
27. M. Bozza, A. R. Satoskar, G. Lin et al. , "Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis, " Journal of ExperimentalMedicine, vol. 189, no. 2, pp. 341-346, 1999.
28. F. K. Swirski, M. J. Pittet, M. F. Kircher et al. , "Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10340-10345, 2006.
29. Y.-U. Lee, T. Yi, S. Tara et al. , "Implantation of inferior vena cava interposition graft in mouse model, " Journal of Visualized Experiments, no. 88, Article ID e51632, 2014.
30. J. K. H. Tan and H. C. ONeill, "Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity, " Journal of Leukocyte Biology, vol. 78, no. 2, pp. 319-324, 2005.
31. J. Aliberti, C. Reis E Sousa, M. Schito et al. , "CCR5 provides a signal for microbial induced production of IL-12 by CD8α + dendritic cells, "Nature Immunology, vol. 1, no. 1, pp. 83-87, 2000.
32. G. S. Yap and A. Sher, "Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)- γ-and tumor necrosis factor (TNF)-α-dependent host resistance to the intracellular pathogen, Toxoplasma gondii, " The Journal of Experimental Medicine, vol. 189, no. 7, pp. 1083-1092, 1999.
33. I. A. Khan, J. D. Schwartzman, T. Matsuura, and L. H. Kasper, "A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 25, pp. 13955-13960, 1997.
34. T. M. Scharton-Kersten, G. Yap, J. Magram, and A. Sher, "Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii, " Journal of Experimental Medicine, vol. 185, no. 7, pp. 1261-1273, 1997.
35. M. Deckert-Schluter, H. Bluethmann, A. Rang, H. Hof, and D. Schluter, "Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis, " The Journal of Immunology, vol. 160, no. 7, pp. 3427-3436, 1998.
36. N. V. Serbina, T. P. Salazar-Mather, C. A. Biron, W. A. Kuziel, and E. G. Pamer, "TNF/iNOS-producing dendritic cellsmediate innate immune defense against bacterial infection, " Immunity, vol. 19, no. 1, pp. 59-70, 2003.
37. M. Schmid, A. K. Wege, and U. Ritter, "Characteristics of Tip-DCs and MDSCs and their potential role in leishmaniasis, " Frontiers in Microbiology, vol. 3, p. 74, 2012.
38. M. Guilliams, K. Movahedi, T. Bosschaerts et al. , "IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection, " The Journal of Immunology, vol. 182, no. 2, pp. 1107-1118, 2009.
39. T. Bosschaerts, M. Guilliams, B. Stijlemans et al. , "Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-γ and MyD88 signaling, " PLoS Pathogens, vol. 6, no. 8, Article ID e1001045, 2010.
40. L. Leng, C. N. Metz, Y. Fang et al. , "MIF signal transduction initiated by binding to CD74, " The Journal of Experimental Medicine, vol. 197, no. 11, pp. 1467-1476, 2003.
41. M. Tarnowski, K. Grymula, R. Liu et al. , "Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts, " Molecular Cancer Research, vol. 8, no. 10, pp. 1328-1343, 2010.
42. F. Geissmann, S. Jung, and D. R. Littman, "Blood monocytes consist of two principal subsets with distinct migratory properties, " Immunity, vol. 19, no. 1, pp. 71-82, 2003.
43. K. Bieber and S. E. Autenrieth, "Insights how monocytes and dendritic cells contribute and regulate immune defense against microbial pathogens, " Immunobiology, vol. 220, no. 2, pp. 215-226, 2015.
44. C. Auffray, D. Fogg, M. Garfa et al. , "Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior, " Science, vol. 317, no. 5838, pp. 666-670, 2007.
45. C. Sunderkotter, T. Nikolic, M. J. Dillon et al. , "Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response, " Journal of Immunology, vol. 172, no. 7, pp. 4410-4417, 2004.
46. I. R. Dunay, A. Fuchs, and L. D. Sibley, "Inflammatory monocytes but not neutrophils are necessary to control infection with Toxoplasma gondii in mice, " Infection and Immunity, vol. 78, no. 4, pp. 1564-1570, 2010.
47. L. M. Neal and L. J. Knoll, "Toxoplasma gondii profilin promotes recruitment of Ly6Chi CCR2+ inflammatory monocytes that can confer resistance to bacterial infection, " PLoS Pathogens, vol. 10, no. 6, Article ID e1004203, 2014.
48. S. B. Cohen, K. J. Maurer, C. E. Egan, S. Oghumu, A. R. Satoskar, and E. Y. Denkers, "CXCR3-dependent CD4+ T cells are required to activate inflammatory monocytes for defense against intestinal infection, " PLoS Pathogens, vol. 9, no. 10, Article ID e1003706, 2013.
49. I. R. Dunay, R. A. DaMatta, B. Fux et al. , "Gr1+ inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii, " Immunity, vol. 29, no. 2, pp. 306-317, 2008.
50. A. Biswas, D. Bruder, S. Wolf et al. , "Ly6Chigh monocytes control cerebral toxoplasmosis, "TheJournal of Immunology, vol. 194, no. 7, pp. 3223-3235, 2015.
51. R. S. Goldszmid, P. Caspar, A. Rivollier et al. , "NK cellderived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection, " Immunity, vol. 36, no. 6, pp. 1047-1059, 2012.
52. C.-Y. Hsieh, C.-L. Chen, Y.-S. Lin et al. , "Macrophagemigration inhibitory factor triggers chemotaxis of CD74+CXCR2+NKT cells in chemically induced IFN-γ-mediated skin inflammation, " Journal of Immunology, vol. 193, no. 7, pp. 3693-3703, 2014.
53. R. Janssen, A. Van Wengen, E. Verhard et al. , "Divergent role for TNF-α in IFN-γ-induced killing of Toxoplasma gondii and Salmonella typhimurium contributes to selective susceptibility of patients with partial IFN-γ receptor 1 deficiency, " Journal of Immunology, vol. 169, no. 7, pp. 3900-3907, 2002.
54. R. T. Gazzinelli, A. Brezin, Q. Li, R. B. Nussenblatt, and C. C. Chan, "Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-α and IFN-γ, " Experimental Parasitology, vol. 78, no. 2, pp. 217-229, 1994.
55. R. T. Gazzinelli, M. Wysocka, S. Hayashi et al. , "Parasiteinduced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii, " Journal of Immunology, vol. 153, no. 6, pp. 2533-2543, 1994.
56. J. Bernhagen, R. Krohn, H. Lue et al. , "MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment, " Nature Medicine, vol. 13, no. 5, pp. 587-596, 2007.
57. D. Schluter, M. Deckert-Schluter, E. Lorenz, T. Meyer, M. Rollinghoff, and C. Bogdan, "Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice, " The Journal of Immunology, vol. 162, no. 6, pp. 3512-3518, 1999.
58. N. M. Silva, J. C. M. Vieira, C. M. Carneiro, and W. L. Tafuri, "Toxoplasma gondii: the role of IFN-γ, TNFRp55 and iNOS in inflammatory changes during infection, " Experimental Parasitology, vol. 123, no. 1, pp. 65-72, 2009.
59. C. Reis e Sousa, S. Hieny, T. Scharton-Kersten et al. , "In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas, " Journal of Experimental Medicine, vol. 186, no. 11, pp. 1819-1829, 1997.